During this National Cancer Control Awareness Month, The Cancer Institute of New Jersey (CINJ) is highlighting its clinical trial program and the importance of patients having access to quality information about these cancer studies right at their fingertips. CINJ is a Center of Excellence of UMNDJ-Robert Wood Johnson Medical School.

As New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, CINJ currently enrolls more than 1,000 patients in prevention, treatment and supportive care trials, including approximately 15 percent of all new adult cancer patients and approximately 70 percent of all pediatric cancer patients. Enrollment in clinical trials nationwide is fewer than five percent of all adult cancer patients…